Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

NCT04358081 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid-19

Interventions

DRUG: HCQ
DRUG: HCQ+AZT
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals